Clinical Trial Update: Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH) [Phase 4]

View source ↗

Summary

A Phase 4 pediatric trial evaluating Tirosint-SOL and tablet formulations of levothyroxine for congenital hypothyroidism was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism

Drugs mentioned

• Levothyroxine (tablet formulations) (Levothyroxine sodium)
• Tirosint-SOL (Levothyroxine sodium oral solution)

Snippet

Sponsor: IBSA Institut Biochimique SA | Conditions: Congenital Hypothyroidism | Phase 4 | Status: TERMINATED